Tatton Asset Management PLC (TAM.L) stock: key figures, P/E, revenue and dividend
Financials · United Kingdom · ISIN GB00BYX1P358
Tatton Asset Management PLC financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 45.00 m GBP | 54.44 m GBP |
| Gross profit | 0.00 GBP | 54.44 m GBP |
| Operating income | – | 24.33 m GBP |
| EBIT | 20.00 m GBP | – |
| Net income | 16.00 m GBP | 18.84 m GBP |
| Diluted EPS – continuing operations | 0.26 GBP | 0.30 GBP |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Tatton Asset Management PLC
Tatton Asset Management plc, through its subsidiaries, operates as an on-platform model portfolio services discretionary fund managers in the United Kingdom. It operates through Tatton and Paradigm segments. The company also offers investment management for model portfolios and multi-manager funds; compliance consultancy and technical support services to independent financial advisers; and mortgage and insurance product distribution services. In addition, it provides regulatory compliance support and mortgage and protection proposition services. Tatton Asset Management plc was incorporated in 2017 and is based in Wilmslow, the United Kingdom.
More stocks
- Wuhu Sanlian Forging Co Ltd (001282.SZ)
- Yoantion Industrial Inc.Ltd. (301053.SZ)
- Nanjing Well Pharmaceutical Co Ltd (603351.SS)
- Shenzhen Refond Optoelectronics Co Ltd (300241.SZ)
- Azzas 2154 S.A. (AZZA3.SA)
- COLONY BANKCORP INC (CBAN)
- PCL Technologies Inc (4977.TW)
- Zhejiang Xiantong Rubber&Plastic Co Ltd (603239.SS)
- DXN HOLDINGS BHD. (5318.KL)
- LIGHTPATH TECHNOLOGIES INC (LPTH)
- VAALCO ENERGY INC /DE/ (EGY)
- Steminent Biotherapeutics Inc. (7729.TWO)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.